Armin Spura became a Strategic Advisor and Board Observer to SeromYx in Oct 2021 and was elected to the Board in 2022. Dr. Spura is currently Chief Executive Officer at global CRDMO BioDuro. He joined BioDuro from Crown Bioscience, where he served as the Chief Executive Officer (CEO) for nearly five years, guiding the company through significant growth and strategic development. Throughout his career, Armin has held senior leadership positions at well-known organizations such as Thermo Fisher Scientific, WuXi NEXTCODE, CareDx and Ion Torrent. Early in his career, Armin helped to grow two startup companies, Ingenuity Systems (acquired by Qiagen) and ForteBio (now part of Danaher). Armin studied biochemistry in Germany and received his Doctor of Philosophy (PhD) in molecular biology from Brown University.